Showing results (261-270 of 386) with videos related to
Sort By:
Pageof 39
Journal of Virology|September 30, 2011
H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillanceSurender Khurana, Pretty Sasono, Annette Fox, et al.Biorxiv : the Preprint Server for Biology|August 1, 2026
Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutininLara S U Schwab, Ruopeng Xie, Ellie Reilly, et al.Journal of Virology|November 6, 2009
The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell deathEric C Freundt, Li Yu, Cynthia S Goldsmith, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.Nature|September 30, 2015
The soft palate is an important site of adaptation for transmissible influenza virusesSeema S Lakdawala, Akila Jayaraman, Rebecca A Halpin, et al.Vaccine|May 14, 2021
Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016Vivian K Y Leung, Annette Fox, Louise A Carolan, et al.The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.BMC Infectious Diseases|April 1, 2006
Reversion of the ELISPOT test after treatment in Gambian tuberculosis casesAlexander M Aiken, Philip C Hill, Annette Fox, et al.Plos One|December 22, 2006
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaPhilip C Hill, Roger H Brookes, Annette Fox, et al.Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.Pageof 39